Effectiveness and Safety of Home-Based Red Blood Cell Transfusion in Terminally Ill Cancer Patients.

Effectiveness and Safety of Home-Based Red Blood Cell Transfusion in Terminally Ill Patients with Hematological Malignancies and Solid Tumors: A Retrospective Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1010250010

Enrollment

100

Registered

2025-06-09

Start date

2025-06-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignancies solid tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We retrospectively analyzed patients who received home-based RBC transfusion. Eligible patients had terminal-stage hematological malignancies or solid tumors and were enrolled in our home medical care program.

Exclusion criteria

Exclusion criteria: Eligibility required prior transfusion experience in hospital or in outpatient department without severe AEs such as anaphylactic shock, transfusion-related acute lung injury, and transfusion-associated circulatory overload and absence of unstable angina, severe heart failure, severe renal failure, or significant allergic predisposition.

Design outcomes

Primary

Measure	Time frame
effectiveness of home-based RBC transfusion	—

Secondary

Measure	Time frame
Safety of home-based RBC transfusion	—

Contacts

Public ContactNaohiro Miyashita

HOME CARE CLINIC N-CONCEPT

nconcept.miyashita@gmail.com+81-80-8049-0177

Outcome results